Lv11
40 积分 2023-05-22 加入
The blood–tumour barrier in cancer biology and therapy
6天前
已完结
Amivantamab plus chemotherapy vs chemotherapy as first-line treatment among patients with EGFR exon 20 insertion–mutated advanced non-small cell lung cancer (NSCLC): PAPILLON Chinese subgroup analysis
7天前
已完结
Core element characterization of Rhodococcus promoters and development of a promoter-RBS mini-pool with different activity levels for efficient gene expression
14天前
已完结
A novel molecular chaperone GroEL2 from Rhodococcus ruber and its fusion chimera with nitrile hydratase for co-enhanced activity and stability
14天前
已完结
Overproduction of the Escherichia coli Chaperones GroEL-GroES in Rhodococcus ruber Improves the Activity and Stability of Cell Catalysts Harboring a Nitrile Hydratase
14天前
已完结
Advances in acrylamide bioproduction catalyzed with Rhodococcus cells harboring nitrile hydratase
14天前
已完结
Non-fucosylated therapeutic antibodies as next-generation therapeutic antibodies
1个月前
已完结
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
1个月前
已完结
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
1个月前
已完结
A randomized phase 2 study of HLX22 plus trastuzumab biosimilar HLX02 and XELOX as first-line therapy for HER2-positive advanced gastric cancer
3个月前
已完结
皖公网安备34019202002308
